Mutares Shares Offer 87% Upside — If the Debt Story Holds Together

Mutares trades near lows despite Cantor Fitzgerald's €48 target. A massive SABIC acquisition and debt repair plan test investor confidence.

The gap between what analysts see in Mutares and what the market is willing to pay for it has rarely been wider. Cantor Fitzgerald just lifted its price target to €48, implying an 87% gain from Monday’s closing price of €25.25. Yet the stock sits barely 7% above its April low of €23.60 and roughly 32% below the 52-week high set last summer.

That disconnect comes down to one word: leverage.

Mutares is pushing ahead with the largest acquisition in its history — the $450 million purchase of SABIC’s Engineering Thermoplastics (ETP) business — while simultaneously trying to repair a balance sheet that tripped a covenant wire in fiscal 2025. The deal will create a new “Chemicals & Materials” segment, add eight production sites, and inject a billion euros in revenue. But it also piles more debt onto a holding company that has already breached its bond terms.

Bondholders granted a reprieve, suspending formal compliance checks until the end of June 2026. That gives management roughly 14 months to bring net debt relative to equity back inside the agreed limits. The plan is straightforward: beginning this spring, Mutares will buy back at least €25 million of its own bonds every quarter. By year-end, the outstanding bond volume should fall from €385 million to no more than €300 million.

The operational engine, at least, is running smoothly. Group revenue climbed 23% to €6.5 billion in 2025, while holding-level net profit rose from €108 million to €130 million, juiced by the lucrative sale of Steyr Motors. For 2026, management is targeting revenue of €7.9 billion to €9.1 billion and holding profit of €165 million to €200 million. The longer-term ambition is even bolder: 25% compound annual growth in both top and bottom lines through 2030.

Fresh equity arrived in April to fund the next leg. A capital increase raised €105 million gross, earmarked primarily for U.S. expansion. Mutares already has a Chicago office and has identified an acquisition pipeline in America worth roughly €4.8 billion in revenue. A second U.S. location is in the works.

Cantor Fitzgerald sees the international push and the SABIC deal as the main growth drivers, but it also highlights the dividend as a buffer. The proposed €2.00 per share payout for 2025 yields nearly 8% at the current price — a combination of growth story and income that the broker finds attractive.

Possible exits in energy and defense later this year could provide additional catalysts, as could clean quarterly numbers that convince the market the deleveraging plan is on track. The first real test comes on May 12, when Mutares reports first-quarter results. That print will show whether the buyback schedule is working and whether the critical leverage ratio is moving in the right direction.

At €26.05 on Tuesday, the stock notched a small gain. But year-to-date it still carries a double-digit loss. The volatility reflects a market that likes the story but isn’t ready to pay for it — not yet.